1597. Ceftolozane-Tazobactam and Meropenem Synergy Testing Against Multi-Drug and Extensively-Drug Resistant Pseudomonas aeruginosa

BACKGROUND: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) have limited therapeutic options for treatment. Ceftolozane/tazobactam is a newer anti-pseudomonal drug effective against resistant PA infections, however resistance against this drug has now also...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Mary Francine P, Nida, Syeda Sara, Lawhorn, Jerry, Koirala, Janak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777695/
http://dx.doi.org/10.1093/ofid/ofaa439.1777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777695/
http://dx.doi.org/10.1093/ofid/ofaa439.1777

Ejemplares similares